InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
InspireMD (Nasdaq: NSPR), the developer of the CGuard™ Prime carotid stent system for treating carotid artery disease and stroke prevention, has announced its upcoming participation at the Bank of America 2025 Healthcare Conference.
The presentation is scheduled for Wednesday, May 14, 2025, at 1:15PM Eastern Time (10:15AM Pacific Time). Interested parties can access both the live audio webcast and a 90-day replay through the "News & Events" section on InspireMD's official website at inspiremd.com/en/events/.
InspireMD (Nasdaq: NSPR), sviluppatore del sistema di stent carotideo CGuard™ Prime per il trattamento della malattia carotidea e la prevenzione dell'ictus, ha annunciato la sua prossima partecipazione alla Bank of America 2025 Healthcare Conference.
La presentazione è prevista per mercoledì 14 maggio 2025, alle 13:15 ora Eastern (10:15 ora Pacific). Gli interessati potranno seguire sia la trasmissione audio in diretta sia la replica disponibile per 90 giorni nella sezione "News & Events" sul sito ufficiale di InspireMD all'indirizzo inspiremd.com/en/events/.
InspireMD (Nasdaq: NSPR), desarrollador del sistema de stent carotídeo CGuard™ Prime para el tratamiento de la enfermedad carotídea y la prevención del accidente cerebrovascular, ha anunciado su próxima participación en la Bank of America 2025 Healthcare Conference.
La presentación está programada para el miércoles 14 de mayo de 2025 a la 1:15 p.m. hora del Este (10:15 a.m. hora del Pacífico). Las personas interesadas podrán acceder tanto a la transmisión de audio en vivo como a una repetición disponible por 90 días a través de la sección "News & Events" en el sitio web oficial de InspireMD en inspiremd.com/en/events/.
InspireMD (나스닥: NSPR)는 경동맥 질환 치료 및 뇌졸중 예방을 위한 CGuard™ Prime 경동맥 스텐트 시스템 개발사로서, 다가오는 Bank of America 2025 Healthcare Conference에 참가할 예정임을 발표했습니다.
발표는 2025년 5월 14일 수요일 동부 표준시 오후 1시 15분(태평양 표준시 오전 10시 15분)에 예정되어 있습니다. 관심 있는 분들은 InspireMD 공식 웹사이트의 "News & Events" 섹션 inspiremd.com/en/events/에서 라이브 오디오 웹캐스트와 90일 동안 재청취가 가능한 녹화 영상을 이용할 수 있습니다.
InspireMD (Nasdaq : NSPR), développeur du système de stent carotidien CGuard™ Prime pour le traitement de la maladie carotidienne et la prévention des AVC, a annoncé sa prochaine participation à la Bank of America 2025 Healthcare Conference.
La présentation est prévue le mercredi 14 mai 2025 à 13h15 heure de l'Est (10h15 heure du Pacifique). Les personnes intéressées pourront accéder à la fois au webcast audio en direct et à un replay disponible pendant 90 jours via la section "News & Events" sur le site officiel de InspireMD à l'adresse inspiremd.com/en/events/.
InspireMD (Nasdaq: NSPR), Entwickler des CGuard™ Prime Karotis-Stentsystems zur Behandlung von Karotisarterienerkrankungen und Schlaganfallprävention, hat seine bevorstehende Teilnahme an der Bank of America 2025 Healthcare Conference angekündigt.
Die Präsentation ist für Mittwoch, den 14. Mai 2025, um 13:15 Uhr Eastern Time (10:15 Uhr Pacific Time) geplant. Interessierte können sowohl den Live-Audio-Webcast als auch eine 90-tägige Wiederholung über den Bereich "News & Events" auf der offiziellen Website von InspireMD unter inspiremd.com/en/events/ abrufen.
- Company gains visibility through presentation at major Bank of America healthcare conference
- None.
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the Bank of America 2025 Healthcare Conference on Wednesday, May 14, 2025, at 1:15PM Eastern Time / 10:15AM Pacific Time.
A live audio webcast and replay of the presentation may be accessed for 90 days on the “News & Events” section of the company’s website at: https://www.inspiremd.com/en/events/
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
When is InspireMD (NSPR) presenting at the Bank of America Healthcare Conference 2025?
How can I watch InspireMD's (NSPR) Bank of America Healthcare Conference presentation?
What does InspireMD (NSPR) specialize in?
Where can I find the replay of InspireMD's (NSPR) May 2025 Bank of America presentation?
What medical device does NSPR showcase at the 2025 Bank of America Healthcare Conference?
